ATOPIC DERMATITIS (AD)

This completed trial tested a herbal ointment made from Syzygium formosum leaves in 90 people with mild to moderate atopic dermatitis (eczema). The ointment was compared to standard moisturizers to see if it was safe and effective. The study measured skin severity, water loss, an…

This study looks at how safe and effective upadacitinib is for Chinese adolescents and adults with moderate to severe atopic dermatitis (eczema). About 200 participants will take the drug as prescribed by their doctor and be followed for up to 24 months. The goal is to track seri…

This completed Phase 2 trial tested a new ointment called CGB-500 (containing tofacitinib) against an approved cream (ruxolitinib) for atopic dermatitis, a type of eczema. Only 3 people aged 12 and older took part, applying both treatments to different skin areas twice daily for …

This study looked at how safe and effective upadacitinib is for Korean patients with rheumatoid arthritis, atopic dermatitis, ankylosing spondylitis, or psoriatic arthritis. Over 2,300 adults took the drug as prescribed by their doctor and were followed for about 28 weeks. Resear…

This study tested whether a cream containing N-acetyl cysteine (NAC) could improve mild-to-moderate eczema better than plain cold cream. One hundred people with eczema used either the NAC cream or a placebo cold cream. Researchers measured changes in skin bacteria (Staph) and ecz…

This study tested an experimental drug called LW402 in 144 adults with moderate-to-severe atopic dermatitis (eczema). The goal was to see if it safely reduces skin redness, thickness, and itching. Participants received either the drug or a placebo, and doctors measured skin impro…

This Phase 3 study tested MH004 ointment in 375 adolescents and adults with mild to moderate atopic dermatitis (eczema). Participants applied the ointment or a placebo twice daily for 4 weeks, followed by a 44-week safety extension. The main goals were to see if the ointment coul…

This early-stage study tested a cream called VC005 in 11 adolescents aged 12 to 18 with mild to moderate eczema. The main goal was to check safety and how the body processes the drug. Researchers measured drug levels in the blood and looked for side effects.

This study tested a new ointment called CGB-500, which contains the drug tofacitinib, for treating eczema (atopic dermatitis) in 180 people aged 12 and older. Participants applied the ointment or a placebo daily for 8 weeks. The goal was to see if it safely reduces skin redness, …

This early-stage trial tested a new oral drug called ENV-294 in 9 adults with moderate-to-severe atopic dermatitis (eczema). Participants took the drug once daily for 28 days and had weekly checkups. The main goal was to see if the drug is safe and tolerable, while also looking f…

This 56-day study tested a cream containing CBD and cherimoya fruit extract on 42 children and adults with mild-to-moderate atopic dermatitis (eczema). Participants applied the cream twice daily. Researchers measured skin redness, dryness, itching, and sleep quality. The goal was…

This study tested an experimental drug, EVO301, in 71 adults with moderate-to-severe atopic dermatitis (eczema). The goal was to see if it safely reduces skin redness, thickness, and itch. Participants received either EVO301 or a placebo, and doctors measured changes in skin seve…

This study tested a high-SPF sunscreen on 42 adults with mild to moderate atopic dermatitis (eczema). Over 22 days, doctors checked how well the skin tolerated the sunscreen and if it helped protect the skin barrier. The goal was to see if the product is safe and comfortable for …

This study tested a broad-spectrum SPF50+ sunscreen on 22 children with mild-to-moderate atopic dermatitis (eczema). The goal was to see how well the children's skin tolerated the sunscreen when applied at least twice daily. Doctors rated tolerance as excellent, very good, good, …

This study tested an ointment called MH004 in 160 healthy volunteers and people with mild to moderate atopic dermatitis (eczema). The goal was to check safety and how well it reduces skin symptoms like redness and itching. The ointment was applied to the skin daily for several we…

This phase 3 trial tested a once-daily cream called roflumilast (0.15%) in 354 people aged 6 and older with mild to moderate atopic dermatitis (eczema). Participants applied the cream or a placebo for 4 weeks. The main goal was to see if the cream could make skin clear or almost …

This study looked at whether the drug dupilumab, used for eczema or asthma, is safe during pregnancy. Researchers compared 581 pregnant women who took dupilumab with those who did not. They tracked birth defects, miscarriages, and infant health up to one year old to see if the dr…